Shaping sustainable paths for HIV/AIDS funding: a review and reminder
- PMID: 40213211
- PMCID: PMC11981258
- DOI: 10.1097/MS9.0000000000002976
Shaping sustainable paths for HIV/AIDS funding: a review and reminder
Abstract
The fight against human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) has made significant progress over the past decades, yet sustainable funding remains a critical challenge. Despite advances in medical treatments and prevention methods, the financial resources needed to combat the epidemic consistently face uncertainties and shortfalls. As of 2023, approximately 37.7 million people are living with HIV/AIDS globally, with 1.5 million new infections reported annually. Sub-Saharan Africa remains the hardest-hit region, accounting for 67% of the global HIV burden. This paper examines the current state of HIV/AIDS funding, identifying key gaps and challenges in maintaining adequate financial resources. It highlights the effects of funding fluctuations on treatment accessibility, prevention programs, and research, stressing the urgent need for diversified and innovative financing mechanisms. The paper offers actionable insights into sustainable funding strategies by analyzing successful models such as public-private partnerships and social impact bonds. This review aims to inform policymakers, stakeholders, and the global community about the financial barriers to HIV/AIDS management and advocate for coordinated efforts to secure stable funding pathways. Ensuring consistent financial support is vital to preserving hard-won progress, expanding access to care, and achieving the ultimate goal of an AIDS-free generation.
Keywords: HIV/AIDS funding; global health financing; innovative funding models; public-private partnerships; sustainable financial strategies.
Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors declare no conflicts of interest or financial disclosures related to this research. The views and opinions expressed in this paper are solely those of the authors and do not necessarily reflect any institution or organization’s official policy or position.
Similar articles
-
Innovative approaches to HIV/AIDS financing: lessons learned from the Sustainable Financing Initiative (SFI).BMC Health Serv Res. 2025 May 28;24(Suppl 1):1669. doi: 10.1186/s12913-025-12529-8. BMC Health Serv Res. 2025. PMID: 40437408 Free PMC article. Review.
-
Global, regional, and national burden of HIV/AIDS, 1990-2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021.Lancet HIV. 2024 Dec;11(12):e807-e822. doi: 10.1016/S2352-3018(24)00212-1. Epub 2024 Nov 25. Lancet HIV. 2024. PMID: 39608393 Free PMC article.
-
[Private companies: an opportunity for hepatitis B virus (HBV) prevention and care in Ivory Coast in the wake of HIV/AIDS?].Bull Soc Pathol Exot. 2015 Feb;108(1):57-62. doi: 10.1007/s13149-014-0402-5. Epub 2014 Nov 18. Bull Soc Pathol Exot. 2015. PMID: 25407333 French.
-
Economic and demographic consequences of AIDS in Namibia: rapid assessment of the costs.Int J Health Plann Manage. 1997 Oct-Dec;12(4):315-26. doi: 10.1002/(SICI)1099-1751(199710/12)12:4<315::AID-HPM492>3.0.CO;2-A. Int J Health Plann Manage. 1997. PMID: 10177418
-
The 2023 Latin America report of the Lancet Countdown on health and climate change: the imperative for health-centred climate-resilient development.Lancet Reg Health Am. 2024 Apr 23;33:100746. doi: 10.1016/j.lana.2024.100746. eCollection 2024 May. Lancet Reg Health Am. 2024. PMID: 38800647 Free PMC article. Review.
Cited by
-
Strengthening anal cancer prevention in Abuja, Nigeria: Identifying barriers and potential strategies to improve training.PLOS Glob Public Health. 2025 Jul 2;5(7):e0004616. doi: 10.1371/journal.pgph.0004616. eCollection 2025. PLOS Glob Public Health. 2025. PMID: 40601571 Free PMC article.
References
-
- Justiz Vaillant AA, Gulick PG. HIV and AIDS Syndrome. StatPearls. Updated September 20, 2022. Accessed June 13, 2024. https://www.ncbi.nlm.nih.gov/b
-
- Kaiser Family Foundation. In 2022, donor governments spent $8.2 billion on efforts to fight HIV/AIDS globally. KFF; 2023. Accessed June 13, 2024. https://www.kff.org/global-hea
-
- Eggleton JS, Nagalli S. Highly Active Antiretroviral Therapy (HAART). In: StatPearls. StatPearls Publishing; 2023.
-
- Ten Brink D, Martin-Hughes R, Kelly SL, et al. . What is the impact of a 20% funding cut in international HIV aid from the United States? AIDS 2019;33:1406–08. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous